Ronald Damhuis

5.6k total citations · 1 hit paper
118 papers, 3.9k citations indexed

About

Ronald Damhuis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Ronald Damhuis has authored 118 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 64 papers in Oncology and 23 papers in Epidemiology. Recurrent topics in Ronald Damhuis's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (30 papers). Ronald Damhuis is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (30 papers). Ronald Damhuis collaborates with scholars based in Netherlands, United Kingdom and France. Ronald Damhuis's co-authors include Harry J. de Koning, Gerrit Draisma, Rob Boer, Suzie J. Otto, F.H. Schröder, Ries Kranse, J.W.W. Coebergh, Anne‐Marie C. Dingemans, Jules L. Derks and Harry J.M. Groen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Ronald Damhuis

112 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

2003 771 citations Ronald Damhuis et al. profile →

Peers

Countries citing papers authored by Ronald Damhuis

Since Specialization

Citations

This map shows the geographic impact of Ronald Damhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Damhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Damhuis more than expected).

Fields of papers citing papers by Ronald Damhuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Damhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Damhuis. The network helps show where Ronald Damhuis may publish in the future.

Co-authorship network of co-authors of Ronald Damhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Damhuis. A scholar is included among the top collaborators of Ronald Damhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Damhuis. Ronald Damhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Applied first-line systemic treatments, treatment modifications and outcomes in non-oncogenic metastatic non-small cell lung cancer in the Netherlands in 2019–2020: A nationwide study 2025 ·Cancer Epidemiology ·(unknown), Natalie D. Veen, William Jacobs, Ronald Damhuis, Cornelia F. van Uden–Kraan, E.M.W. van de Garde	0
2	Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer 2024 ·Acta chirurgica Belgica ·(unknown), Adrianus J. de Langen, Kim Monkhorst, (unknown), Houke M. Klomp, Jasper Smit, Egbert F. Smit, Ronald Damhuis, Koen J. Hartemink	1
3	Optimising primary molecular profiling in non-small cell lung cancer 2024 ·PLoS ONE ·Robert D. Schouten, (unknown), (unknown), Vincent van der Noort, Ronald Damhuis, Erik H.F.M. van der Heijden, (unknown), Nicole P. Barlo, Anne S. R. van Lindert, (unknown), (unknown), Annet Smit, (unknown), B. Maat, Ed Schuuring, Hans Blaauwgeers, Stefan M. Willems, Kim Monkhorst, Daan van den Broek, Michel M. van den Heuvel	1
4	Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective 2024 ·The Lancet Regional Health - Europe ·Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, Ronald Damhuis, Noemı́ Reguart, Mariano Provencio, Antonin Lévy, Rafał Dziadziuszko, Cecilia Pompili, Massimo Di Maïo, Michael Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan, Idris Bahce	17
5	OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid 2024 ·Modern Pathology ·Laura Moonen, Jules L. Derks, Michael A. den Bakker, Lisa M. Hillen, Robert Jan van Suylen, Jan H. von der Thüsen, (unknown), (unknown), Ronald Damhuis, Kim M. Smits, Esther C. van den Broek, Wieneke A. Buikhuisen, Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel	3
6	Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids 2024 ·Journal of Thoracic Oncology ·(unknown), Laura Moonen, Jan H. von der Thüsen, Michael A. den Bakker, Lisa M. Hillen, (unknown), Axel zur Hausen, Thierry van den Bosch, (unknown), Ronald Damhuis, Niki L. Reynaert, Esther C. van den Broek, Lynnette Fernandez‐Cuesta, (unknown), (unknown), (unknown), Anne‐Marie C. Dingemans, (unknown), Jules L. Derks	6
7	Disease relapse in relation to lymph node sampling in lung carcinoid patients 2024 ·Endocrine Related Cancer ·Laura Moonen, Jules L. Derks, Lisa M. Hillen, Robert Jan van Suylen, Michael den Bakker, Jan H. von der Thüsen, Ronald Damhuis, (unknown), Esther C. van den Broek, Jos G. Maessen, Alexander P.W.M. Maat, Paul Van Schil, Ernst‐Jan M. Speel, Anne‐Marie C. Dingemans	4
8	Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands 2023 ·Lung Cancer ·(unknown), Ronald Damhuis, Joachim G.J.V. Aerts, Anne‐Marie C. Dingemans	7
9	Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study 2023 ·The Lancet Regional Health - Europe ·(unknown), Ronald Damhuis, Anthonie J. van der Wekken, Lizza Hendriks, Harry J.M. Groen, Wouter H. van Geffen	24
10	A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses 2021 ·Cancers ·(unknown), (unknown), Chantal C. H. J. Kuijpers, Ronald Damhuis, Anthonie J. van der Wekken, Harry J.M. Groen, Ed Schuuring, Stefan M. Willems, Léon C.L.T. van Kempen	12
11	Risk of second primary malignancies among patients with carcinoid of the lung 2020 ·Lung Cancer ·Wieneke A. Buikhuisen, (unknown), Liudmila L. Kodach, Margot Tesselaar, Ronald Damhuis	1
12	Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study 2019 ·Annals of Surgical Oncology ·Nadine L. de Boer, (unknown), Ronald Damhuis, Joachim G.J.V. Aerts, Cornelis Verhoef, Eva V. E. Madsen	19
13	A Population-Based Study of Outcomes in Surgically Resected T3N0 Non–Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm 2018 ·Journal of Thoracic Oncology ·Hans Blaauwgeers, Ronald Damhuis, Birgit I. Lissenberg‐Witte, Adrianus J. de Langen, Suresh Senan, Erik Thunnissen	11
14	De gezondheidseffecten van roken : groei van kennis leidt tot steeds grimmiger beeld 2017 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Johan P. Mackenbach, Ronald Damhuis, Jasper V. Been	1
15	Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium 2017 ·Clinical Oncology ·Iris Walraven, Ronald Damhuis, Martijn Geert ten Berge, (unknown), Liesbet Van Eycken, Dirk De Ruysscher, J. Belderbos	29
16	Single Organ Metastatic Disease, a New Prognostic Factor for Overall Survival (OS) in Stage IV Non-Small Cell Lung Cancer (NSCLC) 2015 ·Annals of Oncology ·Lizza Hendriks, Jules L. Derks, Pieter E. Postmus, Ronald Damhuis, Ruud Houben, Esther G.C. Troost, M. Hochstenbag, Egbert F. Smit, Anne‐Marie C. Dingemans	1
17	Volwassen kankerpatiënten overleven langer in Nederland 5-jaarsoverleving 12% toegenomen tussen 1989-1993 en 2004-2008 2011 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Sabine Siesling, Otto Visser, (unknown), Henrike E. Karim‐Kos, Lonneke V. van de Poll‐Franse, Katja K.H. Aben, Ronald Damhuis	2
18	Adult cancer patients survive longer in the Netherlands: 5-Year survival rate increased by 12% between 1989-1993 and 2004-2008 2011 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Sabine Siesling, Otto Visser, (unknown), Henrike E. Karim‐Kos, Lonneke van de Poll‐Franse, Katja K.H. Aben, Ronald Damhuis	1
19	Weinig lokaal recidieven na mammachirurgie: goede kwaliteit van de Nederlandse borstkankerzorg 2010 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Margriet van der Heiden‐van der Loo, Vincent K.Y. Ho, Ronald Damhuis, Sabine Siesling, (unknown), Petra H.M. Peeters, Emiel J. Rutgers	3
20	Malignant mesothelioma in the Rotterdam area, 1987–1989 1993 ·European Journal of Cancer ·Ronald Damhuis, Teun van Gelder	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact